These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36111557)

  • 21. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
    Riccò M
    Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Mendlovic F; Plett-Torres T; Alcántar-Fernández J
    Sci Rep; 2022 Mar; 12(1):5241. PubMed ID: 35347208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
    Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students.
    Lee CC; Segaloff HE; Cole D; Rosenblum HG; Morgan CN; Somers T; Desamu-Thorpe R; Foster MA; Currie D; Ruff J; Payne D; Whyte TJ; Abedi GR; Bigouette JP; Kahrs J; Langolf K; Remington P; Sterkel A; Kelly P; Westergaard RP; Bateman AC; Hsu CH; Tate JE; Kirking HL
    BMC Infect Dis; 2022 Mar; 22(1):314. PubMed ID: 35361140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K
    PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany.
    Neumann M; Aigner A; Rossow E; Schwarz D; Marschallek M; Steinmann J; Stücker R; Koenigs I; Stock P
    World J Pediatr; 2021 Oct; 17(5):484-494. PubMed ID: 34415560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.
    Coltart CEM; Wells D; Sutherland E; Fowler A
    BMJ Open; 2021 Jul; 11(7):e049703. PubMed ID: 34257096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal Rise in Seroprevalence of SARS-CoV-2 Infections in Children in Western Germany-A Blind Spot in Epidemiology?
    Brinkmann F; Diebner HH; Matenar C; Schlegtendal A; Spiecker J; Eitner L; Timmesfeld N; Maier C; Lücke T
    Infect Dis Rep; 2021 Nov; 13(4):957-964. PubMed ID: 34842714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
    Stringhini S; Zaballa ME; Pullen N; Perez-Saez J; de Mestral C; Loizeau AJ; Lamour J; Pennacchio F; Wisniak A; Dumont R; Baysson H; Richard V; Lorthe E; Semaani C; Balavoine JF; Pittet D; Vuilleumier N; Chappuis F; Kherad O; Azman AS; Posfay-Barbe K; Kaiser L; Guessous I;
    Euro Surveill; 2021 Oct; 26(43):. PubMed ID: 34713799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.
    Theuring S; Thielecke M; van Loon W; Hommes F; Hülso C; von der Haar A; Körner J; Schmidt M; Böhringer F; Mall MA; Rosen A; von Kalle C; Kirchberger V; Kurth T; Seybold J; Mockenhaupt FP;
    Euro Surveill; 2021 Aug; 26(34):. PubMed ID: 34448448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany.
    Sorg AL; Hufnagel M; Doenhardt M; Diffloth N; Schroten H; von Kries R; Berner R; Armann J
    Eur J Pediatr; 2022 Oct; 181(10):3635-3643. PubMed ID: 35962242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.
    Rashid-Abdi M; Krifors A; Sälléber A; Eriksson J; Månsson E
    Infect Dis (Lond); 2021 Mar; 53(3):169-175. PubMed ID: 33232190
    [No Abstract]   [Full Text] [Related]  

  • 37. Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
    Ayrolles A; Ellul P; Trebossen V; Houhou-Fidouh N; Bonacorsi S; Descamps D; Delorme R
    Neuropsychopharmacol Rep; 2022 Jun; 42(2):218-220. PubMed ID: 35257512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumulative incidence, prevalence, seroconversion, and associated factors for SARS-CoV-2 infection among healthcare workers of a University Hospital in Bogotá, Colombia.
    Valderrama-Beltrán SL; Cuervo-Rojas J; Ariza B; Cardozo C; Ángel J; Martinez-Vernaza S; Juliana Soto M; Arcila J; Salgado D; Rondón M; Cepeda M; Castellanos JC; Gómez-Restrepo C; Franco MA
    PLoS One; 2022; 17(9):e0274484. PubMed ID: 36121816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
    Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
    HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Rates of SARS-CoV-2 Family Transmission in Children of Healthcare Workers During the First Pandemic Wave in Madrid, Spain: Serologic Study.
    Méndez-Echevarría A; Sainz T; de Felipe B; Alcolea S; Olbrich P; Goycochea-Valdivia WA; Escosa-García L; Cobo L; Calvo C; Neth O
    Pediatr Infect Dis J; 2021 May; 40(5):e185-e188. PubMed ID: 33591078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.